Corcept Therapeutics (CORT)
71.80 +0.09 (+0.13%) 14:24 ET [NASDAQ]
71.70 x 48 71.88 x 19
Realtime by (Cboe BZX)
71.70 x 48 71.88 x 19
Realtime 73.38 +1.67 (+2.33%) 09:30 ET
for Mon, Apr 28th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 141,209 | 106,140 | 101,418 | 112,512 | 106,011 |
| Depreciation Amortization | -9,602 | -6,766 | 4,829 | 8,559 | 2,237 |
| Income taxes - deferred | -40,191 | -29,493 | -33,905 | 4,346 | 14,089 |
| Accounts receivable | -12,853 | -10,066 | -3,432 | -1,427 | -6,270 |
| Accounts payable and accrued liabilities | -2,248 | 5,778 | 4,757 | -3,597 | 3,161 |
| Other Working Capital | 45,297 | 8,218 | 5,539 | -466 | -5,357 |
| Other Operating Activity | 76,455 | 53,228 | 41,117 | 47,965 | 38,099 |
| Operating Cash Flow | $198,067 | $127,039 | $120,323 | $167,892 | $151,970 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -588,310 | -328,748 | -355,066 | 136,595 | 302,089 |
| PPE Investments | -2,172 | -139 | -413 | -469 | -1,238 |
| Purchase Of Investment | 412,878 | 419,793 | 241,152 | N/A | -420,114 |
| Investing Cash Flow | $-177,604 | $90,906 | $-114,327 | $136,126 | $-119,263 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 9,616 | 5,811 | 4,381 | 16,229 | 23,226 |
| Common Stock Repurchased | -15,664 | -145,428 | N/A | -295,985 | -9,945 |
| Other Financing Activity | -22,301 | -9,106 | -21,665 | -22,835 | -1,067 |
| Financing Cash Flow | $-28,349 | $-148,723 | $-17,284 | $-302,591 | $12,214 |
| Beginning Cash Position | 135,551 | 66,329 | 77,617 | 76,190 | 31,269 |
| End Cash Position | 127,665 | 135,551 | 66,329 | 77,617 | 76,190 |
| Net Cash Flow | $-7,886 | $69,222 | $-11,288 | $1,427 | $44,921 |
| Free Cash Flow | |||||
| Operating Cash Flow | 198,067 | 127,039 | 120,323 | 167,892 | 151,970 |
| Capital Expenditure | -2,172 | -139 | -413 | -469 | -1,238 |
| Free Cash Flow | 195,895 | 126,900 | 119,910 | 167,423 | 150,732 |